Michael Petusky
Stock Analyst at Barrington
(3.51)
# 2,296
Out of 4,698 analysts
657
Total ratings
44%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Maintained: Buy | $6.25 | $4.40 | +42.05% | 40 | Sep 3, 2026 | |
| VMD Viemed Healthcare | Initiated Coverage: Buy | $14 | $9.08 | +54.19% | 1 | Aug 24, 2026 | |
| HAE Haemonetics | Maintained: Buy | $95 → $118 | $102.92 | +14.65% | 67 | Aug 19, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Buy | $17 → $15 | $11.38 | +31.81% | 57 | Aug 10, 2026 | |
| USPH U.S. Physical Therapy | Maintained: Buy | $90 → $98 | $79.35 | +23.50% | 60 | Aug 10, 2026 | |
| LMAT LeMaitre Vascular | Downgraded: Hold | $120 → $95 | $80.67 | +17.76% | 57 | Aug 6, 2026 | |
| OFIX Orthofix Medical | Maintained: Buy | $17 → $14 | $9.29 | +50.70% | 13 | Aug 6, 2026 | |
| BVS Bioventus | Maintained: Buy | $14 → $18 | $14.07 | +27.93% | 7 | Aug 6, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $97 → $104 | $89.81 | +15.80% | 46 | Aug 5, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $107 → $114 | $89.60 | +27.23% | 82 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $21 | $20.81 | +0.91% | 50 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $33 | $24.21 | +36.31% | 58 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.64 | - | 54 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 → $1.5 | $0.604 | +148.34% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.015 | n/a | 44 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $54.53 | n/a | 1 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $30 | $25.54 | n/a | 1 | Apr 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6.5 | $1.01 | n/a | 1 | Aug 14, 2013 |
Lifecore Biomedical
Sep 3, 2026
Maintained: Buy
Price Target: $6.25
Current: $4.40
Upside: +42.05%
Viemed Healthcare
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $9.08
Upside: +54.19%
Haemonetics
Aug 19, 2026
Maintained: Buy
Price Target: $95 → $118
Current: $102.92
Upside: +14.65%
DENTSPLY SIRONA
Aug 10, 2026
Maintained: Buy
Price Target: $17 → $15
Current: $11.38
Upside: +31.81%
U.S. Physical Therapy
Aug 10, 2026
Maintained: Buy
Price Target: $90 → $98
Current: $79.35
Upside: +23.50%
LeMaitre Vascular
Aug 6, 2026
Downgraded: Hold
Price Target: $120 → $95
Current: $80.67
Upside: +17.76%
Orthofix Medical
Aug 6, 2026
Maintained: Buy
Price Target: $17 → $14
Current: $9.29
Upside: +50.70%
Bioventus
Aug 6, 2026
Maintained: Buy
Price Target: $14 → $18
Current: $14.07
Upside: +27.93%
Henry Schein
Aug 5, 2026
Maintained: Buy
Price Target: $97 → $104
Current: $89.81
Upside: +15.80%
Merit Medical Systems
Jul 31, 2026
Maintained: Buy
Price Target: $107 → $114
Current: $89.60
Upside: +27.23%
Jul 30, 2026
Maintained: Buy
Price Target: $17 → $21
Current: $20.81
Upside: +0.91%
Jul 30, 2026
Maintained: Buy
Price Target: $32 → $33
Current: $24.21
Upside: +36.31%
Jul 28, 2026
Maintained: Hold
Price Target: n/a
Current: $1.64
Upside: -
Jan 6, 2026
Maintained: Buy
Price Target: $1 → $1.5
Current: $0.604
Upside: +148.34%
May 12, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.015
Upside: n/a
Jun 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $54.53
Upside: n/a
Dec 18, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 25, 2016
Upgraded: Buy
Price Target: $30
Current: $25.54
Upside: n/a
Aug 14, 2013
Rated: Buy
Price Target: $6.5
Current: $1.01
Upside: n/a